MedTrace Logo

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions

NCT00611910 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 610

Last updated 2011-05-13

No results posted yet for this study

Summary

The aim of this study is to compare the efficacy of drug-eluting stents and bare metal stents to reduce reblockage of bypass grafts after coronary stenting

Conditions

  • Arteriosclerosis of Arterial Coronary Artery Bypass Graft

Interventions

DEVICE

sirolimus-eluting stent

due to randomization Cypher stent will be implanted

DEVICE

paclitaxel-eluting stent

due to randomization Taxus stent will be implanted

DEVICE

biodegradable-polymer-based sirolimus-eluting stent

due to randomization a rapamycin-eluting stent with biodegradable polymer will be implanted

DEVICE

bare metal stents

Due to randomization one bare-metal stent will be implanted. The decision about the stent type will be up to the interventionalist

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Julinda Mehilli, MD · Deutsches Herzzentrum Muenchen

  • Adnan Kastrati, MD · Deutsches Herzzentrum Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611910 on ClinicalTrials.gov